A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor
Clinical trial NCT03791112 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03791112
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-18
- Primary completion
- 2025-12-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.